Three Strikes For Generic Advair With An FDA CRL For Sandoz

 
• By Jessica Merrill

Novartis' generic drug unit confirmed the receipt of a complete response letter from the US FDA for a generic version of GlaxoSmithKline's Advair, following similar CRLs for Mylan and Hikma.

Baseball Pitcher Throwing ball, selective focus

More from New Products

More from Scrip